FilingReader Intelligence
Baijin Life Science cuts annual loss to HK$0.1m
July 24, 2025 at 05:09 PM UTC•By FilingReader AI
Baijin Life Science Holdings Limited expects its annual loss for the year ended 31 March 2025 to fall dramatically to approximately HK$0.1 million from HK$8.5 million the prior year.
The improvement stems from increased revenue and gross profit from its jewellery business, plus higher reversal of credit loss allowances.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:1466•Hong Kong Exchange
News Alerts
Get instant email alerts when Affluent Partner Hold publishes news
Free account required • Unsubscribe anytime